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A 76-year-old man with a past medical history of hyper-tension only presented to the hospital with dry non-
productive cough, pleuritic chest pain, and dyspnea. 
Computed tomographic (CT) angiography scan revealed 
a ‘filling defect’ in the left main pulmonary artery (Fig. 
1A). Unfractionated heparin was started and bridged to 
Coumadin. No deep venous thrombus was revealed on 
the upper and lower extremities duplex venous scans. 
The patient was discharged home with the diagnosis of 
pulmonary thromboembolism (PTE). After discharge, 
the patient’s symptoms kept worsening with additional 
anorexia and weight loss despite the ongoing anticoagula-
tion treatment. Due to the worsening dyspnea and a weight 
loss of 20 pounds over the next 12 months, a follow-up 
CT-chest angiogram was performed which revealed a large 
16 × 10 × 8 cm mass in the left main pulmonary artery which 
seemed to have originated from the filling defect seen on 
the initial CT-scan (Figs. 1B–D). An ultrasound-guided 
biopsy of the mass was consistent with the diagnosis of 
pulmonary artery sarcoma (PAS) (Fig. 2). Due to the exten-
sive disease, only the palliative chemotherapy was offered, 
which the patient declined.
Described first by Mandelstamm1 in 1923, PAS is a 
rare and often lethal tumor which is usually diagnosed only 
during surgery or autopsy. They are thought to arise from 
the mesenchymal cells of the intima of pulmonary artery 
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FIGURE 1. A, Computed tomographic scan (CT)-
chest (with contrast) showing a filling defect in the 
left main pulmonary artery (arrow), (B), CT scan-chest 
(with contrast) a year later showing large left medias-
tinal mass (arrow), (C), CT scan-chest (with contrast), 
coronal reconstruction showing large mediastinal 
tumor (arrow), (D), CT scan chest (with contrast), 
sagittal reconstruction showing the same tumor origi-
nating from the pulmonary artery (arrow).
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trunk or the bulbous cordis.2 PAS is often misdiagnosed as 
PTE, as both of the diseases initially appear as intraluminal 
‘filling defects’ in the pulmonary artery system on contrast 
enhanced CT scans. The differentiation between these two 
disease entities is very important to avoid misdiagnosis 
of a potentially fatal malignancy and unnecessary antico-
agulation therapy. An absence of predisposing factors for 
PTE and the progressive worsening dyspnea in the patients 
with an intraluminal “filling defect” despite anticoagulation 
therapy are factors suggestive of PAS. Recently, it has been 
reported that, positron emission tomographic scan may help 
to make a differential diagnosis between PAS and PTE.3 
Surgical resection in conjunction with neoadjuvant chemo-
therapy remains the primary treatment, if detected early in 
the course of the disease.4
Clinicians should maintain high clinical suspicion of 
PAS in patients with a filling defect in the pulmonary artery 
without any underlying risk factors for PTE and worsening of 
the symptoms despite anticoagulation therapy.
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FIGURE 2. A, Histopathological examination 
(hematoxylin-eosin stain) demonstrates spindle cells 
with pleomorphic nuclei in a myxoid and collage-
nized background. B, Immunohistochemical analysis 
showing diffuse positivity of tumor cells to vimentin 
stain, a marker of tumors of mesenchymal origin 
including sarcomas.
